Overview
Minjun Yao practices practicing medicine in Hangzhou, China.
Their clinical expertise encompasses Primary Lateral Sclerosis, Osteolysis Syndrome Recessive, Bone Tumor, and Lung Metastases.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Minjun Yao
Is Minjun Yao a top-rated expert for Primary Lateral Sclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Minjun Yao is classified as an Experienced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Minjun Yao participate in research or clinical trials?
Yes. Minjun Yao has published 16 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Minjun Yao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorYao isExperienced. Learn about Bone Tumor.
- Lung MetastasesYao isExperienced. Learn about Lung Metastases.
- Osteolysis Syndrome Recessive
- OsteoporosisYao isExperienced. Learn about Osteoporosis.
- Primary Lateral SclerosisYao isExperienced. Learn about Primary Lateral Sclerosis.